LOC105375501 (Gene)

Description:uncharacterized LOC105375501

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View LOC105375501's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with LOC105375501.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using LOC105375501.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for LOC105375501.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with LOC105375501.

Results found

Linked to

	Label	Description
	GSE140322 imatinib K-562 C.M.L. 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140322 SRSF1 overexpression K-562 C.M.L. Imatinib 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE81796 enzalutamide LNCaP C4-2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 0 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140322 imatinib K-562 C.M.L. 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140322 SRSF1 overexpression K-562 C.M.L. Imatinib 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE140322 imatinib K-562 C.M.L. 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE140322 SRSF1 overexpression K-562 C.M.L. Imatinib 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE81796 enzalutamide LNCaP C4-2 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE201309 matrine 1 v 8 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 lenalidomide 0 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 lenalidomide 0 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE140322 imatinib K-562 C.M.L. 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE140322 SRSF1 overexpression K-562 C.M.L. Imatinib 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.